Ally Bridge Group »

Abivax SA F shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.4M 70k 134.86

More positions owned by Ally Bridge Group

Replimune Group Call Option (REPL)
Edgewise Therapeutics (EWTX)
Abivax Sa Sponsored Ads (ABVX)
Soleno Therapeutics (SLNO)
Compass Pathways Sponsored Ads Call Option (CMPS)
Atai Beckley Nv SHS
Inventiva Sa Ads (IVA)
Minerva Neurosciences Com New (NERV)
Praxis Precision Medicines I Com New (PRAX)
Taysha Gene Therapies Com Shs (TSHA)
Uniqure Nv SHS Call Option (QURE)
Eupraxia Pharmaceuticals (EPRX)
Ovid Therapeutics (OVID)
Solid Biosciences Com New (SLDB)
Aadi Bioscience (WHWK)

View all positions for Ally Bridge Group

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Cormorant Asset Management
Paradigm Biocapital Advisors
Caligan Partners
FMR
Octagon Capital Advisors
ADAR1 Capital Management
Barclays
Millennium Management
Westfield Capital Management Company
Vestal Point Capital
Adage Capital Partners GP

View all funds holding Abivax SA F